墨西哥基于粪便免疫化学检测的大肠癌筛查初步经验
在墨西哥韦拉克鲁斯开展2015-16年基于粪便免疫化学检测(FIT)的大肠癌筛查试点,向50-75岁成人发放473份FIT试剂盒,85.8%完成检测,5.9%结果>100 ng血红蛋白/ml并转诊结肠镜,FIT阳性对癌前病变的阳性预测值为33%。结果提供个体愿意完成FIT筛查的初步证据,但大规模实施前需进一步评估卫生系统资源。
要点
- 50-75岁成人中85.8%完成FIT检测,显示较高接受度。
- FIT>100 ng血红蛋白/ml者中5.9%为阳性,阳性对癌前病变阳性预测值33%。
- 大规模实施前需评估卫生系统资源。
核心结论
- 结果提供墨西哥个体愿意完成基于FIT的大肠癌筛查程序的初步证据。
- 大规模实施大肠癌筛查程序前需进一步评估卫生系统资源。
研究设计与样本
- 2015-16年在墨西哥韦拉克鲁斯开展基于FIT的大肠癌筛查试点。
- 向50-75岁成人发放473份FIT试剂盒,FIT结果>100 ng血红蛋白/ml者转诊诊断性结肠镜。
主要发现
- 473份FIT试剂盒中85.8%(406份)由参与者完成并在实验室分析。
- 406份中5.9%(24/406)结果>100 ng血红蛋白/ml。
- FIT>100 ng血红蛋白/ml对癌前病变的阳性预测值为33%。
关键数值与推荐
- FIT结果>100 ng血红蛋白/ml者转诊诊断性结肠镜。
- FIT>100 ng血红蛋白/ml对癌前病变的阳性预测值为33%。
临床怎么用
- 在50-75岁成人中可考虑使用FIT作为大肠癌筛查工具,阳性者转诊结肠镜。
局限性
- 结果为初步证据,大规模实施前需进一步评估卫生系统资源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In middle-income countries, the burden of colorectal cancer (CRC) is increasing in parallel with resources for diagnosis and treatment. There is a potential benefit of CRC screening programs in Mexico. OBJECTIVE: Since there are no organized screening programs in the country, we explored the willingness of individuals to complete a faecal immunochemical testing (FIT) based CRC screening program and its potential benefit in Mexico. METHODS: We conducted a CRC screening program pilot in Veracruz, Mexico, during 2015-16 using FIT. Individuals with FIT results >100 ng of haemoglobin/ml buffer were referred for diagnostic colonoscopy. RESULTS: Of 473 FIT kits distributed to adults aged 50-75, 85.8% (406) were completed by participants and analysed in the laboratory. Of these, 5.9% (24/406) of test results showed >100 ng haemoglobin/ml. Twenty-one participants completed colonoscopy. The positive predictive value of FIT >100 ng haemoglobin/ml for premalignant lesions was 33%. CONCLUSION: These results provide preliminary evidence of the willingness of individuals to complete FIT-based CRC screening program in Mexico. However, further evaluation of health systems resources will be needed prior to large-scale implementation of CRC screening programs.
引用
- Remes-Troche JM, Hinojosa-Garza G, Espinosa-Tamez P, et al. Faecal immunochemical test-based colorectal cancer screening in Mexico: an initial experience. Fam Pract. 2020. PMID: 31961429. doi:10.1093/fampra/cmz078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。